AL
Anavex Life Sciences Corp
🇩🇪XSTU.12X1GermanyHealthcare
€2.10EURup +0.05 (+2.44%)ClosedEnd of day10:42 PM
Price€2.10+0.05 (+2.44%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US0327973006
- CUSIP
- Not reported
Company
- Employees
- 34
- Headquarters
- New York, United States
- Website
- https://www.anavex.com
- CEO
- Dr. Terrie Kellmeyer Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$0.26
- P/E LTM
- -9.93
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$24.04M+50.09%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$33.73M+9.08%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.